{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:14Z","timestamp":1792787834443,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82172227"],"award-info":[{"award-number":["82172227"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16465-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:48:22Z","timestamp":1784605702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FOXM1-associated melanoma stratification: integrated multi-omics and experimental validation reveal prognostic significance and therapeutic potential"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1729-2141","authenticated-orcid":false,"given":"Zhichen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4089-3374","authenticated-orcid":false,"given":"Zhenpeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0429-1496","authenticated-orcid":false,"given":"Luying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-1073","authenticated-orcid":false,"given":"Ran","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"3","key":"16465_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"16465_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"16465_CR3","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/jama.2025.13074","volume":"334","author":"UM Joshi","year":"2025","unstructured":"Joshi UM, Kashani-Sabet M, Kirkwood JM. Cutaneous Melanoma: A Review. JAMA. 2025;334(23):2113\u201325.","journal-title":"JAMA"},{"issue":"10400","key":"16465_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA. Cutaneous melanoma. Lancet. 2023;402(10400):485\u2013502.","journal-title":"Lancet"},{"issue":"1","key":"16465_CR5","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"16465_CR6","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10197","key":"16465_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0140-6736(19)31132-8","volume":"394","author":"D Utj\u00e9s","year":"2019","unstructured":"Utj\u00e9s D, Malmstedt J, Teras J, Drzewiecki K, Gullestad HP, Ingvar C, Eriksson H, Gillgren P. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2\u00a0mm: long-term follow-up of a multicentre, randomised trial. Lancet. 2019;394(10197):471\u20137.","journal-title":"Lancet"},{"issue":"2","key":"16465_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1470-2045(15)00482-9","volume":"17","author":"AJ Hayes","year":"2016","unstructured":"Hayes AJ, Maynard L, Coombes G, Newton-Bishop J, Timmons M, Cook M, Theaker J, Bliss JM, Thomas JM. Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial. Lancet Oncol. 2016;17(2):184\u201392.","journal-title":"Lancet Oncol"},{"issue":"1","key":"16465_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jaad.2021.08.011","volume":"87","author":"RJ Straker","year":"2022","unstructured":"Straker RJ 3rd, Kelly N, Sharon CE, Shannon AB, Xu X, Elder DE, Chu EY, Miura JT, Karakousis GC. Local recurrence in patients undergoing wide excision and sentinel lymph node biopsy for cutaneous malignant melanoma: A single-center, retrospective cohort analysis. J Am Acad Dermatol. 2022;87(1):247\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"16465_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaad.2022.09.040","volume":"88","author":"AB Shannon","year":"2023","unstructured":"Shannon AB, Sharon CE, Straker RJ 3rd, Carr MJ, Sinnamon AJ, Bogatch K, Thaler A, Kelly N, Vetto JT, Fowler G, et al. Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: A multicenter cohort study. J Am Acad Dermatol. 2023;88(1):52\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"16465_CR11","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jaad.2022.11.004","volume":"88","author":"TJ Knackstedt","year":"2023","unstructured":"Knackstedt TJ. Differences in sentinel lymph node biopsy utilization in eligible melanoma patients treated with Mohs micrographic surgery or wide local excision: A population-based logistic regression model and survival analysis. J Am Acad Dermatol. 2023;88(4):848\u201355.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"16465_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jaad.2022.07.058","volume":"87","author":"NA Ran","year":"2022","unstructured":"Ran NA, Nugent ST, Veerabagu SA, Chu EY, Modi MB, Sobanko JF, Etzkorn JR, Shin TM, Higgins HW 2nd, Giordano CN, et al. Desmoplastic melanoma treated with wide local excision or Mohs micrographic surgery: Rates of positive margins, local recurrence, and repeat surgeries. J Am Acad Dermatol. 2022;87(6):1376\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"16465_CR13","doi-asserted-by":"crossref","unstructured":"Bell KJL, Soyer HP, Ferguson PM. Is Wide Local Excision After Primary Excision of Melanoma In Situ Unnecessary? JAMA Dermatol. 2025.","DOI":"10.1001\/jamadermatol.2025.3077"},{"issue":"7","key":"16465_CR14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.annonc.2021.03.198","volume":"32","author":"F Dimitriou","year":"2021","unstructured":"Dimitriou F, Long GV, Menzies AM. Novel adjuvant options for cutaneous melanoma. Ann Oncol. 2021;32(7):854\u201365.","journal-title":"Ann Oncol"},{"key":"16465_CR15","doi-asserted-by":"publisher","first-page":"175883592211340","DOI":"10.1177\/17588359221134087","volume":"14","author":"I Kobeissi","year":"2022","unstructured":"Kobeissi I, Tarhini AA. Systemic adjuvant therapy for high-risk cutaneous melanoma. Ther Adv Med Oncol. 2022;14:17588359221134087.","journal-title":"Ther Adv Med Oncol"},{"key":"16465_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.critrevonc.2015.12.002","volume":"99","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Liu W, Gotlieb V. The rapidly evolving therapies for advanced melanoma\u2013Towards immunotherapy, molecular targeted therapy, and beyond. Crit Rev Oncol Hematol. 2016;99:91\u20139.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"16465_CR17","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1001\/jamaoncol.2020.4401","volume":"6","author":"R Dummer","year":"2020","unstructured":"Dummer R, Ascierto PA, Nathan P, Robert C, Schadendorf D. Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A Review. JAMA Oncol. 2020;6(12):1957\u201366.","journal-title":"JAMA Oncol"},{"issue":"9","key":"16465_CR18","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41591-024-03077-5","volume":"30","author":"GV Long","year":"2024","unstructured":"Long GV, Carlino MS, Au-Yeung G, Spillane AJ, Shannon KF, Gyorki DE, Hsiao E, Kapoor R, Thompson JR, Batula I, et al. Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAF(V600)-mutant resectable melanoma: the randomized phase 2 NeoTrio trial. Nat Med. 2024;30(9):2540\u20138.","journal-title":"Nat Med"},{"issue":"7","key":"16465_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.annonc.2025.03.021","volume":"36","author":"P Grover","year":"2025","unstructured":"Grover P, Lo SN, Li I, Kuijpers AMJ, Kreidieh F, Williamson A, Amaral T, Dimitriou F, Placzke J, Olino K, et al. Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma. Ann Oncol. 2025;36(7):807\u201318.","journal-title":"Ann Oncol"},{"issue":"6","key":"16465_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41591-019-0474-7","volume":"25","author":"RJ Sullivan","year":"2019","unstructured":"Sullivan RJ, Hamid O, Gonzalez R, Infante JR, Patel MR, Hodi FS, Lewis KD, Tawbi HA, Hernandez G, Wongchenko MJ, et al. Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients. Nat Med. 2019;25(6):929\u201335.","journal-title":"Nat Med"},{"issue":"6","key":"16465_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11912-023-01385-6","volume":"25","author":"JP Pham","year":"2023","unstructured":"Pham JP, Joshua AM, da Silva IP, Dummer R, Goldinger SM. Chemotherapy in Cutaneous Melanoma: Is There Still a Role? Curr Oncol Rep. 2023;25(6):609\u201321.","journal-title":"Curr Oncol Rep"},{"key":"16465_CR22","doi-asserted-by":"publisher","first-page":"113976","DOI":"10.1016\/j.ejca.2024.113976","volume":"202","author":"LJ Albrecht","year":"2024","unstructured":"Albrecht LJ, Dimitriou F, Grover P, Hassel JC, Erdmann M, Forschner A, Johnson DB, V\u00e1raljai R, Lodde G, Placke JM, et al. Anti-PD-(L)1 plus BRAF\/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma. Eur J Cancer. 2024;202:113976.","journal-title":"Eur J Cancer"},{"issue":"13","key":"16465_CR23","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1093\/nar\/gkq194","volume":"38","author":"DR Littler","year":"2010","unstructured":"Littler DR, Alvarez-Fern\u00e1ndez M, Stein A, Hibbert RG, Heidebrecht T, Aloy P, Medema RH, Perrakis A. Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence. Nucleic Acids Res. 2010;38(13):4527\u201338.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"16465_CR24","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/ncb1767","volume":"10","author":"Z Fu","year":"2008","unstructured":"Fu Z, Malureanu L, Huang J, Wang W, Li H, van Deursen JM, Tindall DJ, Chen J. Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol. 2008;10(9):1076\u201382.","journal-title":"Nat Cell Biol"},{"issue":"8052","key":"16465_CR25","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41586-024-08421-w","volume":"638","author":"F Xie","year":"2025","unstructured":"Xie F, Zhou X, Ran Y, Li R, Zou J, Wan S, Su P, Meng X, Yan H, Lu H, et al. Targeting FOXM1 condensates reduces breast tumour growth and metastasis. Nature. 2025;638(8052):1112\u201321.","journal-title":"Nature"},{"issue":"10","key":"16465_CR26","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.7150\/thno.55672","volume":"11","author":"X Xiang","year":"2021","unstructured":"Xiang X, Fu Y, Zhao K, Miao R, Zhang X, Ma X, Liu C, Zhang N, Qu K. Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated PHB2. Theranostics. 2021;11(10):4929\u201344.","journal-title":"Theranostics"},{"issue":"5","key":"16465_CR27","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/hep.31196","volume":"72","author":"Y Li","year":"2020","unstructured":"Li Y, Lu L, Tu J, Zhang J, Xiong T, Fan W, Wang J, Li M, Chen Y, Steggerda J, et al. Reciprocal Regulation Between Forkhead Box M1\/NF-\u03baB and Methionine Adenosyltransferase 1A Drives Liver Cancer. Hepatology. 2020;72(5):1682\u2013700.","journal-title":"Hepatology"},{"issue":"1","key":"16465_CR28","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1038\/s41467-025-59186-3","volume":"16","author":"S Timilsina","year":"2025","unstructured":"Timilsina S, Huang JY, Abdelfattah N, Medina D, Singh D, Abdulsahib S, Subbarayalu P, Do TP, Venkata PP, Nirzhor S, et al. Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory. Nat Commun. 2025;16(1):3967.","journal-title":"Nat Commun"},{"issue":"1","key":"16465_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41568-025-00873-0","volume":"26","author":"A Dong","year":"2026","unstructured":"Dong A, Blanpain C. Identification, functional insights and therapeutic targeting of EMT tumour states. Nat Rev Cancer. 2026;26(1):8\u201326.","journal-title":"Nat Rev Cancer"},{"issue":"7532","key":"16465_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/517109a","volume":"517","author":"S Tippmann","year":"2015","unstructured":"Tippmann S. Programming tools: Adventures with R. Nature. 2015;517(7532):109\u201310.","journal-title":"Nature"},{"issue":"2","key":"16465_CR31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018;173(2):400\u2013e416411.","journal-title":"Cell"},{"issue":"3","key":"16465_CR32","doi-asserted-by":"publisher","first-page":"e3000202","DOI":"10.1371\/journal.pbio.3000202","volume":"17","author":"M Postma","year":"2019","unstructured":"Postma M, Goedhart J. PlotsOfData-A web app for visualizing data together with their summaries. PLoS Biol. 2019;17(3):e3000202.","journal-title":"PLoS Biol"},{"issue":"18","key":"16465_CR33","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847\u20139.","journal-title":"Bioinformatics"},{"issue":"5","key":"16465_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284\u20137.","journal-title":"Omics"},{"key":"16465_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"16465_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"16465_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"16465_CR38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395.","journal-title":"Immunity"},{"key":"16465_CR39","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"4","key":"16465_CR40","first-page":"358","volume":"73","author":"AH Fox","year":"2023","unstructured":"Fox AH, Nishino M, Osarogiagbon RU, Rivera MP, Rosenthal LS, Smith RA, Farjah F, Sholl LM, Silvestri GA, Johnson BE. Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide. CA Cancer J Clin. 2023;73(4):358\u201375.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"16465_CR41","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, Cust AE, de Vries E, Whiteman DC, Bray F. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol. 2022;158(5):495\u2013503.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"16465_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/CM9.0000000000003416","volume":"138","author":"M Wang","year":"2025","unstructured":"Wang M, Gao X, Zhang L. Recent global patterns in skin cancer incidence, mortality, and prevalence. Chin Med J (Engl). 2025;138(2):185\u201392.","journal-title":"Chin Med J (Engl)"},{"key":"16465_CR43","doi-asserted-by":"crossref","unstructured":"Reitmajer M, Flatz L. Precision medicine in cutaneous melanoma-A comprehensive review. J Eur Acad Dermatol Venereol. 2025.","DOI":"10.1111\/jdv.70111"},{"issue":"33","key":"16465_CR44","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1200\/JCO.19.00489","volume":"37","author":"C Menzer","year":"2019","unstructured":"Menzer C, Menzies AM, Carlino MS, Reijers I, Groen EJ, Eigentler T, de Groot JWB, van der Veldt AAM, Johnson DB, Meiss F, et al. Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations. J Clin Oncol. 2019;37(33):3142\u201351.","journal-title":"J Clin Oncol"},{"issue":"71","key":"16465_CR45","first-page":"e70566","volume":"2026","author":"Y Fu","year":"2020","unstructured":"Fu Y, Liu J, Mo Z, Wang B, Deng Y, Jiang Y. Melanoma: Pathogenesis and Targeted Therapy. MedComm. 2020;2026(71):e70566.","journal-title":"MedComm"},{"key":"16465_CR46","doi-asserted-by":"publisher","first-page":"218160","DOI":"10.1016\/j.canlet.2025.218160","volume":"638","author":"MA Khan","year":"2026","unstructured":"Khan MA, Khan P, Fatima M, Rehman AU, Anwar L, Alsafwani ZW, Ahmad A, Abbas Zaidi MA, Cox JL, Zahid A, et al. Targeting FOXM1 reshapes antitumor immunity to attenuate small cell lung cancer progression. Cancer Lett. 2026;638:218160.","journal-title":"Cancer Lett"},{"key":"16465_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.03.007","volume":"92","author":"MA Khan","year":"2023","unstructured":"Khan MA, Khan P, Ahmad A, Fatima M, Nasser MW. FOXM1: A small fox that makes more tracks for cancer progression and metastasis. Semin Cancer Biol. 2023;92:1\u201315.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"16465_CR48","doi-asserted-by":"publisher","first-page":"112986","DOI":"10.1016\/j.celrep.2023.112986","volume":"42","author":"A Kobiita","year":"2023","unstructured":"Kobiita A, Silva PN, Schmid MW, Stoffel M. FoxM1 coordinates cell division, protein synthesis, and mitochondrial activity in a subset of \u03b2 cells during acute metabolic stress. Cell Rep. 2023;42(8):112986.","journal-title":"Cell Rep"},{"issue":"1","key":"16465_CR49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cell.2025.11.020","volume":"189","author":"Y Chemla","year":"2026","unstructured":"Chemla Y, Itzhaki O, Melamed S, Weller C, Sade Y, Manich P, Reshef K, Xenidis N, Maliah A, Levy G, et al. HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion. Cell. 2026;189(1):233\u2013e251229.","journal-title":"Cell"},{"issue":"8045","key":"16465_CR50","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-024-08194-2","volume":"637","author":"M Wagner","year":"2025","unstructured":"Wagner M, Nishikawa H, Koyasu S. Reinventing type 2 immunity in cancer. Nature. 2025;637(8045):296\u2013303.","journal-title":"Nature"},{"issue":"2","key":"16465_CR51","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41419-024-06488-x","volume":"15","author":"B Ziman","year":"2024","unstructured":"Ziman B, Yang Q, Zheng Y, Sheth M, Nam C, Zhao H, Zhang L, Hu B, Bhowmick NA, Sinha UK, Lin DC. Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma. Cell Death Dis. 2024;15(2):152.","journal-title":"Cell Death Dis"},{"issue":"10","key":"16465_CR52","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1007\/s11010-025-05322-y","volume":"480","author":"S Du","year":"2025","unstructured":"Du S, Li P, Liu Y, Cai B, Li G, Wang W, Yan R, Zheng X, Bai T. FOXM1 upregulation, promotes immune escape in gastric cancer through activation of Notch signaling pathway. Mol Cell Biochem. 2025;480(10):5411\u201327.","journal-title":"Mol Cell Biochem"},{"key":"16465_CR53","doi-asserted-by":"crossref","unstructured":"Tang Q, Li J, Zhang L, Zeng S, Bao Q, Hu W, He L, Huang G, Wang L, Liu Y, Zhao X, Yang S, Hu C. Orlistat facilitates immunotherapy via AKT-FOXO3a-FOXM1-mediated PD-L1 suppression. J Immunother Cancer. 2025;13(3):e008923.","DOI":"10.1136\/jitc-2024-008923"},{"issue":"1","key":"16465_CR54","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41573-025-01280-8","volume":"25","author":"L Zhang","year":"2026","unstructured":"Zhang L, Wei J, Zou Z, He C. RNA modification systems as therapeutic targets. Nat Rev Drug Discov. 2026;25(1):59\u201378.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"16465_CR55","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41419-024-07108-4","volume":"15","author":"YY Liu","year":"2024","unstructured":"Liu YY, Xia M, Chen ZB, Liao YD, Zhang CY, Yuan L, Pan YW, Huang H, Lu HW, Yao SZ. HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1. Cell Death Dis. 2024;15(10):732.","journal-title":"Cell Death Dis"},{"issue":"1","key":"16465_CR56","doi-asserted-by":"publisher","first-page":"189527","DOI":"10.1016\/j.bbcan.2025.189527","volume":"1881","author":"L Cai","year":"2025","unstructured":"Cai L, Sun X, Li R, Ping Y, Lv S, Chen J. Key methylation modifications in glioma stem cells. Biochim Biophys Acta Rev Cancer. 2025;1881(1):189527.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"35","key":"16465_CR57","doi-asserted-by":"publisher","first-page":"29887","DOI":"10.1074\/jbc.M112.371682","volume":"287","author":"C Bonet","year":"2012","unstructured":"Bonet C, Giuliano S, Ohanna M, Bille K, Allegra M, Lacour JP, Bahadoran P, Rocchi S, Ballotti R, Bertolotto C. Aurora B is regulated by the mitogen-activated protein kinase\/extracellular signal-regulated kinase (MAPK\/ERK) signaling pathway and is a valuable potential target in melanoma cells. J Biol Chem. 2012;287(35):29887\u201398.","journal-title":"J Biol Chem"},{"issue":"6","key":"16465_CR58","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jid.2017.01.021","volume":"137","author":"JA Puig-Butille","year":"2017","unstructured":"Puig-Butille JA, Vinyals A, Ferreres JR, Aguilera P, Cabr\u00e9 E, Tell-Mart\u00ed G, Marcoval J, Mateo F, Palomero L, Badenas C, et al. AURKA Overexpression Is Driven by FOXM1 and MAPK\/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy. J Invest Dermatol. 2017;137(6):1297\u2013310.","journal-title":"J Invest Dermatol"},{"key":"16465_CR59","doi-asserted-by":"publisher","first-page":"116796","DOI":"10.1016\/j.bcp.2025.116796","volume":"233","author":"Q Liu","year":"2025","unstructured":"Liu Q, Hu J, Li X, Gao H, Kong D, Jin M. Glutamine transporter inhibitor enhances the sensitivity of NSCLC to trametinib through GSDME-dependent pyroptosis. Biochem Pharmacol. 2025;233:116796.","journal-title":"Biochem Pharmacol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16465-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:08:43Z","timestamp":1790831323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16465-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16465"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16465-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval for this study was granted by the Ethics Committee of the Provincial Hospital affiliated to Shandong First Medical University for human biomedical research (Approval No. SWYX:2025\u2009\u2212\u2009935). Written informed consent was obtained from all participants prior to inclusion in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No identifiable individual participant data are included in this study. All tissue specimens were anonymized prior to analysis.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1157"}}